Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.

Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Groot Koerkamp B.

Open source

DOI: 10.1093/jnci/djz073
Published: 2019-08-01
Container: J Natl Cancer Inst
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djz073,
  title = {Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.},
  author = {Janssen QP and  Buettner S and  Suker M and  Beumer BR and  Addeo P and  Bachellier P and  Bahary N and  Bekaii-Saab T and  Bali MA and  Besselink MG and  Boone BA and  Chau I and  Clarke S and  Dillhoff M and  El-Rayes BF and  Frakes JM and  Grose D and  Hosein PJ and  Jamieson NB and  Javed AA and  Khan K and  Kim KP and  Kim SC and  Kim SS and  Ko AH and  Lacy J and  Margonis GA and  McCarter MD and  McKay CJ and  Mellon EA and  Moorcraft SY and  Okada KI and  Paniccia A and  Parikh PJ and  Peters NA and  Rabl H and  Samra J and  Tinchon C and  van Tienhoven G and  van Veldhuisen E and  Wang-Gillam A and  Weiss MJ and  Wilmink JW and  Yamaue H and  Homs MYV and  van Eijck CHJ and  Katz MHG and  Groot Koerkamp B.},
  year = {2019},
  journal = {J Natl Cancer Inst},
  doi = {10.1093/jnci/djz073},
  url = {https://doi.org/10.1093/jnci/djz073}
}

RIS

TY  - JOUR
TI  - Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.
AU  - Janssen QP
AU  -  Buettner S
AU  -  Suker M
AU  -  Beumer BR
AU  -  Addeo P
AU  -  Bachellier P
AU  -  Bahary N
AU  -  Bekaii-Saab T
AU  -  Bali MA
AU  -  Besselink MG
AU  -  Boone BA
AU  -  Chau I
AU  -  Clarke S
AU  -  Dillhoff M
AU  -  El-Rayes BF
AU  -  Frakes JM
AU  -  Grose D
AU  -  Hosein PJ
AU  -  Jamieson NB
AU  -  Javed AA
AU  -  Khan K
AU  -  Kim KP
AU  -  Kim SC
AU  -  Kim SS
AU  -  Ko AH
AU  -  Lacy J
AU  -  Margonis GA
AU  -  McCarter MD
AU  -  McKay CJ
AU  -  Mellon EA
AU  -  Moorcraft SY
AU  -  Okada KI
AU  -  Paniccia A
AU  -  Parikh PJ
AU  -  Peters NA
AU  -  Rabl H
AU  -  Samra J
AU  -  Tinchon C
AU  -  van Tienhoven G
AU  -  van Veldhuisen E
AU  -  Wang-Gillam A
AU  -  Weiss MJ
AU  -  Wilmink JW
AU  -  Yamaue H
AU  -  Homs MYV
AU  -  van Eijck CHJ
AU  -  Katz MHG
AU  -  Groot Koerkamp B.
PY  - 2019
JO  - J Natl Cancer Inst
DO  - 10.1093/jnci/djz073
UR  - https://doi.org/10.1093/jnci/djz073
ER  -

APA

QP, J., S, B., M, S., BR, B., P, A., P, B., N, B., T, B., MA, B., MG, B., BA, B., I, C., S, C., M, D., BF, E., JM, F., D, G., PJ, H., NB, J., AA, J., K, K., KP, K., SC, K., SS, K., AH, K., J, L., GA, M., MD, M., CJ, M., EA, M., SY, M., KI, O., A, P., PJ, P., NA, P., H, R., J, S., C, T., G, V. T., E, V. V., A, W., MJ, W., JW, W., H, Y., MYV, H., CHJ, V. E., MHG, K., & B., G. K. (2019). Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djz073

Source records

europe-pmc · retrieved 2026-09-27T02:30:56.873Z
hal · retrieved 2026-09-27T02:30:56.882Z